Xylem Inc (NYSE:XYL) had its price objective cut by Susquehanna from $38.00 to $37.00 in a note issued to investors on Thursday, StockTargetPrices.com reports. Susquehanna’s target price points to a potential upside of 8.73% from the company’s previous close.

Several hedge funds have modified their holdings of XYL. Simplex Trading increased its stake in shares of Xylem by 450.0% in the fourth quarter. Simplex Trading now owns 11 shares of the company’s stock worth $0 after buying an additional 9 shares during the last quarter. CT Financial Advisors increased its stake in shares of Xylem by 18.8% in the fourth quarter. CT Financial Advisors now owns 1,266 shares of the company’s stock worth $46,209 after buying an additional 200 shares during the last quarter. Baker Avenue Asset Management acquired a new stake in shares of Xylem during the third quarter worth about $329,000. Quantitative Systematic Strategies acquired a new stake in shares of Xylem during the fourth quarter worth about $400,000. Finally, Capstone Asset Management Company increased its stake in shares of Xylem by 9.6% in the fourth quarter. Capstone Asset Management Company now owns 12,769 shares of the company’s stock worth $466,000 after buying an additional 1,120 shares during the last quarter.

In other Xylem news, Director Steven R. Loranger sold 165,690 shares of the firm’s stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $36.69, for a total value of $6,079,166.10. Following the completion of the sale, the director now directly owns 9,789 shares of the company’s stock, valued at approximately $359,158.41. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Markos I. Tambakeras sold 2,025 shares of the firm’s stock in a transaction on Thursday, November 12th. The stock was sold at an average price of $36.73, for a total value of $74,378.25. Following the completion of the sale, the director now directly owns 36,144 shares of the company’s stock, valued at $1,327,569.12. The disclosure for this sale can be found here.

Shares of Xylem (NYSE:XYL) opened at 34.03 on Thursday. The stock has a market capitalization of $6.10 billion and a price-to-earnings ratio of 19.32. The stock’s 50 day moving average is $35.62 and its 200-day moving average is $34.79. Xylem has a 52 week low of $29.90 and a 52 week high of $38.00.

Xylem (NYSE:XYL) last announced its earnings results on Thursday, October 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.01. The business had revenue of $902 million for the quarter, compared to analysts’ expectations of $897.80 million. During the same quarter last year, the business earned $0.53 EPS. The company’s quarterly revenue was down 6.3% on a year-over-year basis. On average, analysts anticipate that Xylem will post $1.85 earnings per share for the current fiscal year.

A number of other research analysts have also issued reports on the company. Seaport Global Securities upgraded Xylem from an “accumulate” rating to a “buy” rating and set a $40.00 target price on the stock in a research report on Thursday. Barclays increased their target price on Xylem from $34.00 to $37.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 19th. DA Davidson decreased their target price on Xylem from $38.00 to $35.00 in a research report on Tuesday, January 12th. RBC Capital upgraded Xylem from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $37.00 to $42.00 in a research report on Wednesday, January 6th. Finally, Zacks Investment Research lowered Xylem from a “hold” rating to a “sell” rating in a research report on Monday, January 4th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $38.69.

Xylem Inc. is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment. The Company is an equipment and service provider in various application areas of the water equipment industry: transport, treatment, test, building services, industrial processing and irrigation. The Company’s water market brands, such as Bell & Gossett and Flygt. The Company sells its products in more than 150 countries through a distribution network consisting of direct sales force and independent channel partners. The Company has two business segments: Water Infrastructure (NYSE:XYL) and Applied Water (usage).

12 Month Chart for NYSE:XYL

Stock Target Prices

Receive News & Ratings for Xylem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc and related companies with MarketBeat.com's FREE daily email newsletter.